MLPREANMAL
(MLPREANMAL)Codes and Frequencies
Description
MLPREANMAL indicates whether, in response to an open-ended question, the woman reported taking antimalarial drugs as a way malaria can be avoided.
Comparability — Index
Comparability
Apart from universe differences and slight differences in question wording (described below), MLPREANMAL is comparable across samples.
Comparability - Standard DHS
Prior to Phase 8, MLPREANMAL is a country-specific variable not included in the standard DHS questionnaire. In Phase 8, this variable has the standard name ML503D.
Comparability — Guinea [top]
The 1999 Guinea survey includes "Take nivaquine/chloroquine" as a response category. Nivaquine and chloroquine are both antimalarial drugs.
Universe
- Burkina Faso 2021: All women age 15-49.
- Ghana 2022: All women age 15-49.
- Guinea 1999: Women age 15-49 who know malaria can be prevented.
- Madagascar 2021: All women age 15-49.
- Mali 2018: All women age 15-49.
- Rwanda 2000: All women age 15-49.
- Rwanda 2005: All women age 15-49.
- Tanzania 2022: Women age 15-49 in households selected for the men's survey.